Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utilization of Never-Medicated Bipolar Disorder Patients towards Development and Validation of a Peripheral Biomarker Profile

24 Jun 2013

Abstract excerpt

There are currently no biological tests that differentiate patients with bipolar disorder (BPD) from healthy controls. While there is evidence that peripheral gene expression differences between patients and controls can be utilized as biomarkers for psychiatric illness, it is unclear whether current use or residual effects of antipsychotic and mood stabilizer medication drives much of the differential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bipolar Disorder and Treatment
Share to Genetic Syndromes and Imprinting

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23826396
DOI: 10.1371/journal.pone.0069082

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utilization of Never-Medicated Bipolar Disorder Patients towards Development and Validation of a Peripheral Biomarker ProfilePMID 23826396Read ↗

Coding and Noncoding Gene Expression Biomarkers in Mood Disorders and SchizophreniaSemantic proximity Read ↗

A Discriminating Messenger RNA Signature for Bipolar Disorder Formed by an Aberrant Expression of Inflammatory Genes in MonocytesSemantic proximity Read ↗

Transcriptomic abnormalities in peripheral blood in bipolar disorder, and discrimination of the major psychosesSemantic proximity Read ↗

Putative Transcriptomic Biomarkers in the Inflammatory Cytokine Pathway Differentiate Major Depressive Disorder Patients from Control Subjects and Bipolar Disorder PatientsSemantic proximity Read ↗

Transcriptome profiling as a biological marker for bipolar disorder sub-phenotypes.Semantic proximity Read ↗

Patients with schizophrenia and bipolar disorder display a similar global gene expression signature in whole blood that reflects elevated proportion of immature neutrophil cells with association to lipid changesSemantic proximity Read ↗

Replicable and Coupled Changes in Innate and Adaptive Immune Gene Expression in Two Case-Control Studies of Blood Microarrays in Major Depressive DisorderSemantic proximity Read ↗

A composite peripheral blood gene expression measure as a potential diagnostic biomarker in bipolar disorderSemantic proximity Read ↗

PERIPHERAL BLOOD AS TOOL TO DETERMINE GENE EXPRESSION PATTERNS IN PATIENTS WITH PSYCHIATRIC, NEUROLOGICAL AND OTHER COMMON DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS PROTOCOLSemantic proximity Read ↗

A diagnostic model based on bioinformatics and machine learning to differentiate bipolar disorder from schizophrenia and major depressive disorderSemantic proximity Read ↗

Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approachSemantic proximity Read ↗

Differential gene expression analysis in blood of first episode psychosis patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.